Verve Therapeutics
VERV
#6795
Rank
ยฃ0.38 B
Marketcap
ยฃ4.58
Share price
11.24%
Change (1 day)
-59.34%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ0.12 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are ยฃ0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.12 B13.39%
2022-12-31ยฃ0.10 B434.67%
2021-12-31ยฃ19.83 M-81%
2020-12-31ยฃ0.10 B232.32%
2019-12-31ยฃ31.41 M